Kilpi, Fanny
Soares, Ana Goncalves
Clayton, Gemma L.
Fraser, Abigail
Welsh, Paul
Sattar, Naveed
Nelson, Scott M.
Tilling, Kate
Lawlor, Deborah A.
Funding for this research was provided by:
Medical Research Council (MC_UU_00011/6, MC_UU_00011/6, MC_UU_00011/6, MC_UU_00011/6, MC_UU_00011/6, MC_UU_00011/6)
National Institute for Health and Care Research (NF-0616-10102)
Article History
Received: 22 July 2022
Accepted: 27 September 2022
First Online: 24 November 2022
Declarations
:
: Ethical approval for the data collection in ALSPAC was Granted by the ALSPAC Law and Ethics Committee and the National Health Service Research Ethics Committee (NRES; more details can be found at ExternalRef removed). Informed written consent for the use of data collected via questionnaires and clinics was obtained from participants. Consent for biological samples has been collected in accordance with the Human Tissue Act (2004). All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: AF and KT report funding from UK MRC, DAL reports receiving support from several national and international government and charity research funders, and Grants from Medtronic Ltd for work unrelated to that presented here. SMN reports personal fees from Access Fertility, personal fees from Merck, personal fees from Ferring, Grants and personal fees from Roche Diagnostics, personal fees from The Fertility Partnership and personal fees from Modern Fertility, outside the submitted work. Roche Diagnostics provided support in kind for the hormone assays used in this report, and have not contributed to the statistical analysis plan, analysis of data, interpretation of results or any part of the manuscript. PW declares Grant funding from Roche Diagnostics, Astrazeneca, and Boheringer Ingelheim. FK, ALGS, GLC, NS declare that they have no competing interests.